Cargando…

A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies

Detalles Bibliográficos
Autores principales:	Li, Fubin, Ravetch, Jeffrey V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Editorials: Cell Cycle Features
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466534/ https://www.ncbi.nlm.nih.gov/pubmed/22918247 http://dx.doi.org/10.4161/cc.21842

Ejemplares similares

Genetic Modifiers of Systemic Lupus Erythematosus in FcγRIIB(−/−) Mice
por: Bolland, Silvia, et al.
Publicado: (2002)

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016)

FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells
por: Campos Carrascosa, Lucia, et al.
Publicado: (2020)

The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions
por: Osorio, Juan C., et al.
Publicado: (2023)

Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
por: Dhodapkar, Kavita M., et al.
Publicado: (2007)

Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
por: Dhodapkar, Kavita M., et al.
Publicado: (2007)

Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
por: Georgescu, Maria T., et al.
Publicado: (2020)

The Complex Association of FcγRIIb With Autoimmune Susceptibility
por: Verbeek, J. Sjef, et al.
Publicado: (2019)

Targeting the Antibody Checkpoints to Enhance Cancer Immunotherapy–Focus on FcγRIIB
por: Teige, Ingrid, et al.
Publicado: (2019)

Transmembrane domain dependent inhibitory function of FcγRIIB
por: Wang, Junyi, et al.
Publicado: (2018)

FcγRIIB is a T cell checkpoint in antitumor immunity
por: Farley, Clara R., et al.
Publicado: (2021)

Role of lipid nanodomains for inhibitory FcγRIIb function
por: Spiegel, Franziska, et al.
Publicado: (2023)

γH2AX spreading linked to homology search
por: Renkawitz, Jörg, et al.
Publicado: (2013)

Socs3 induction by PPARγ restrains cancer-promoting inflammation
por: Végran, Frédérique, et al.
Publicado: (2013)

Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131)
por: Mimoto, F., et al.
Publicado: (2013)

FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease model
por: Kam, Tae-In, et al.
Publicado: (2016)

Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking
por: Liu, Luyan, et al.
Publicado: (2022)

FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms
por: Simpson, Alexander P., et al.
Publicado: (2022)

Distinct cell-specific control of autoimmunity and infection by FcγRIIb
por: Brownlie, Rebecca J., et al.
Publicado: (2008)

High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis
por: Magnusson, Sofia E, et al.
Publicado: (2007)

Lupus-like Disease in FcγRIIB(−/−) Mice Induces Osteopenia
por: Visitchanakun, Peerapat, et al.
Publicado: (2019)

Transactivation by low and high levels of human p53 reveals new physical rules of engagement and novel super-transactivation sequences
por: Menendez, Daniel, et al.
Publicado: (2012)

Gene transcription by p53 requires inositol polyphosphate multikinase as a co-activator
por: Xu, Risheng, et al.
Publicado: (2013)

PARty promoters: Hormone-dependent gene regulation requires CDK2 activation of PARP1
por: Wright, Roni H.G., et al.
Publicado: (2012)

Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index
por: Karimifar, Mansoor, et al.
Publicado: (2021)

IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells
por: Gast, Mathias, et al.
Publicado: (2018)

Functional Role of FcγRIIB in the Regulation of Mesenchymal Stem Cell Function
por: Zhu, Tianyi, et al.
Publicado: (2016)

Identification of candidate regulators of mandibular bone loss in FcγRIIB(-/-) Mice
por: Sakunrangsit, Nithidol, et al.
Publicado: (2021)

Inducing Tumor Immunity through the Selective Engagement of Activating Fcγ Receptors on Dendritic Cells
por: Kalergis, Alexis M., et al.
Publicado: (2002)

Negative Signaling Pathways of the Killer Cell Inhibitory Receptor and FcγRIIb1 Require Distinct Phosphatases
por: Gupta, Neetu, et al.
Publicado: (1997)

Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction
por: Wang, Shuang, et al.
Publicado: (2022)

Correction to: Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index
por: Karimifar, Mansoor, et al.
Publicado: (2022)

A requirement for FcγR in antibody-mediated bacterial toxin neutralization
por: Abboud, Nareen, et al.
Publicado: (2010)

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy
por: Hussain, Khiyam, et al.
Publicado: (2022)

B Lymphocyte Memory: Role of Stromal Cell Complement and FcγRIIB Receptors
por: Barrington, Robert A., et al.
Publicado: (2002)

FcγRIIb Balances Efficient Pathogen Clearance and the Cytokine-mediated Consequences of Sepsis
por: Clatworthy, Menna R., et al.
Publicado: (2004)

Dexamethasone Induces FcγRIIb Expression in RBL-2H3 Cells
por: Silwal, Prashanta, et al.
Publicado: (2012)

FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding
por: Hu, Wei, et al.
Publicado: (2019)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021)

Trehalose dimycolate interferes with FcγR-mediated phagosome maturation through Mincle, SHP-1 and FcγRIIB signalling
por: Patin, Emmanuel C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_87tca1sa248jo9m7g4iojah2lh